1. What are Leveraged & Indexed Products?
Leveraged and Indexed (L&I) Products are structured as Exchange Traded Funds (ETFs) and seek to achieve short-term investment results that correspond to the magnified or inverse performance of their underlying benchmarks on a daily basis.
2. What is a Single Stock L&I Product?
A Single Stock L&I Product is a listed leveraged and inverse product using a fund structure that aims to deliver a daily return equivalent to a multiple of a single stock’s return, designed to magnify the gains or losses of an underlying stock and which significantly increases potential risks and rewards through concentration.
3. How many Single Stock L&I Products are listed at HKEX?
Eight Single Stock L&I Products listed at HKEX on 24 March 2025. You may find full details here.
4. What does the expansion to cover Single Stock L&I Products mean for HKEX?
It represents a strategic enhancement of HKEX’s product offerings, facilitating additional investment strategies and attracting a broader investor base by enabling exposure to individual stock performance. HKEX is the first exchange to offer these innovative products in Asia, reinforcing its competitive edge as Asia’s ETP marketplace.
5. What are the benefits and risks of trading Single Stock L&I Products vs Single Stocks?
Single Stock L&I Products amplify daily return of a reference stock or hedge against potential losses. Like ETFs, the risk of L&I Products can include counterparty risk, market risk, tracking errors, trading at discount or premium, and liquidity risk.
6. How is Hong Kong’s ETP market performing?
Hong Kong’s ETP market grew to a record market capitalisation of HK$463 billion in 2024. Building on this momentum, average daily turnover of ETPs in the first two months of 2025 reached HK$36 billion, up 89 per cent from a year earlier.
7. Which ETPs are listed in Hong Kong?
A total of 194 ETPs were listed in Hong Kong at the end of 2024. You may find full details here.